Shijie Wu

Molecular hydrogen: A potential radioprotective agent.

Anwen Shao, Wei Wu, Yongchuan Deng, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition

Yiding Chen, Yunxiang Zhou, Shijie Wu, 2022, Expert opinion on investigational drugs.

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Yihan Yao, Yali Wang, Anwen Shao, 2020, Frontiers in Molecular Biosciences.

Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study

Yihan Yao, Yunxiang Zhou, Shijie Wu, 2023, OncoTargets and therapy.

First‐line CDK4/6 inhibitor‐based combinations for HR+/HER2– advanced breast cancer: A Bayesian network meta‐analysis

Shijie Wu, Lu Shen, Xianan Guo, 2023, Journal of evidence-based medicine.